BI-1839100
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BI-1839100, covering 2024-11-13 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis [Phase 2]